They may also prescribe generic alternatives if GLP-1s arent suitable for you or are unavailable
Spine (Phila Pa 1976)
van Nuland AJM, den Ouden HEM, Zach H, Dirkx MFM, van Asten JJA, Scheenen TWJ, Toni I, Cools R, Helmich RC (2020) GABAergic changes in the thalamocortical circuit in Parkinsons disease
Certificate of Analysis View Third-Party COA (Testides Analytical) 99.55% Purity Batch DBAV-CJCI-10-051226-02 For research purposes only
Clinical trials and real-world data consistently show: Average weight loss of 1520% on semaglutide or tirzepatide Improvements in blood pressure, cholesterol, and blood sugar Reduced risk of developing type 2 diabetes and cardiovascular disease These outcomes are meaningful both for employee health and long-term cost avoidance
Sandoval and DAlessio (2015)